Rock Weekly – NEW

Get the Rock Weekly in your inbox.

Join 50,000+ innovators, enterprise leaders, founders, and investors who subscribe to Rock Weekly for early access to our curated insights

Expert analysis and proprietary data (e.g., longitudinal funding data, consumer adoption) 100% 100%
Insightful takes from the Rock Health Advisory team 100% 100%
Spotlight on startups, deals, partnerships, and emerging trends 100% 100%

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Name Goes Here

U

What happens in Vegas…ends up here

Reflections on HLTH 2025.

The backbone of care

Fresh capital for nursing innovation.

Infrastructure for impact

Announcing Rock Health Capital’s latest investment in Pear Suite.

Q3 digital health funding: $3.5B across 107 deals

Unlabeled raises persist, the middle thins, and infrastructure plays pull ahead.

Falling into place

Market consolidation is shaping up the season.

Need meets opportunity for rural communities

CMS opens $50B gate into rural healthcare innovation.

Wrists and risks

Updates in discovery—physiological and pharmaceutical.

Health system JVs go varsity

Co-dev partnerships tackle provider pressure points.

Flipping the script

Pharma’s new normal is DTP.

Epic goes APE (Art, Penny, and Emmie)

Blurred lines between incumbent | innovator and provider | tech.